InnoCare to Attend Upcoming Investor Conferences to Share Latest Company Development

Beijing, Nov. 9, 2020——InnoCare Pharma (HKEX: 09969), a clinical-stage biopharmaceutical company, announced today that the company executives will attend a series of investor conferences to share company’s latest development in November. Details are as follows:

Asia Pacific Healthcare Corporate Day host by Institutional Capital Advisory (online)

Time: Nov. 10, 2020 (Tuesday)

Format: One on One & Group meeting

CICC Strategy Summit

Time: Nov. 12, 2020 (Thursday) Location: Beijing

Format: Group meeting

Industrial Securities Strategy Summit

Time: Nov. 13, 2020 (Friday) Location: Shanghai

Format: One on One & Group meeting

Bernstein Operational Decisions Conference (Online)

Time: Nov. 16-17, 2020 (Monday & Tuesday)

Format: One on One & Group meeting

Goldman Sachs APAC Healthcare Forum (Online)

Time: Nov. 16-18, 2020

Format: One on One & Group meeting

Morgan Stanley Virtual Asia Pacific Summit

Time: Nov. 18-20, 2020 (Wednesday to Friday)

Format: One on One & Group meeting

CITIC Securities 2021 Capital Market Annual Summit

Time: Nov. 20, 2020 (Friday) Location: Shenzhen

Format: One on One & Group meeting

Guosen Securities 2021 Annual Investment Strategy Conference

Time: Nov. 25-27 (Wednesday to Friday) Location: Shenzhen

Format: One on One & Group meeting

Investors who have interest can contact the organizers to join the above meetings and InnoCare looks forward to having in-depth discussions with investors onsite or online. InnoCare also welcomes investors to contact for meeting arrangements if needed.

About InnoCare Pharma

InnoCare Pharma is a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of first-in-class and/or best-in-class drugs for the treatment of cancer and autoimmune diseases. We strategically focus on lymphoma, solid tumors, and autoimmune disease with high unmet medical needs in China and worldwide. InnoCare has branches in Beijing, Nanjing, Shanghai, Guangzhou, New Jersey, and Boston.